The OPTIONS study was described as a double-blind, placebo-controlled trial in 502 adults with obesity who received oral AOD9604 or placebo once daily for 24 weeks together with a diet-and-exercise program
Animal studies suggest that it reduces NNMT activity, leading to better NAD+ retention, improved metabolic efficiency, and reduced fat mass
Consequently, there is an urgent need for innovative chemical structures and strategies to bolster the stability of bioactive peptides, while the production is convenient and cost-effective
doi: 10.1016/j.cmet.2020.06.008 279 FraylingTMBeaumontRNJonesSEYaghootkarHTukeMARuthKSet al
Each approach carries distinct mechanisms, benefits, and limitations worth comparing
Meanwhile, serum creatine kinase isoenzyme, LDH, and cardiac troponin I leakage were reduced